Ligand profile
ZINC2126459
Virtual-screening candidate from ZINC.
Bound to: KP13_03893 — Succinate-semialdehyde dehydrogenase [NADP+]
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2126459- UniProt (similar protein)
P05091- Tanimoto
- 0.838
- Target protein
- KP13_03893
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 43.4
- −1 ≤ LogP ≤ 5 4.50
- MW ≤ 500 Da 270.3
- LogP ≤ 5 4.50
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 43.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCc1cc(=O)oc2cc3oc(C)c(C)c3cc12CCCCc1cc(=O)oc2cc3oc(C)c(C)c3cc12
InChI=1S/C17H18O3/c1-4-5-6-12-7-17(18)20-16-9-15-13(8-14(12)16)10(2)11(3)19-15/h7-9H,4-6H2,1-3H3InChI=1S/C17H18O3/c1-4-5-6-12-7-17(18)20-16-9-15-13(8-14(12)16)10(2)11(3)19-15/h7-9H,4-6H2,1-3H3
POQAXMPRNAQQHC-UHFFFAOYSA-NPOQAXMPRNAQQHC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL1562069
- Homolog
- P05091
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2126459 →
- ZINC ZINC20 ZINC2126459 →
- UniProt UniProt P05091 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2126459”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03893.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).